From: Advances in novel therapeutic approaches for periodontal diseases
Antibiotic | Dose and Duration | Disease | Findings | Side Effects | References |
---|---|---|---|---|---|
Amoxicillin + Metronidazole | Metronidazole: 250 mg Amoxicillin: 500 mg for 2 years | Stage II periodontitis | Antibiotic treatment decreased probing depth (PD) and gained clinical attachment Five randomized clinical trials showed improvement in PD and bleeding on probing | One participant experienced nausea and vomiting and one developed candidiasis Few participants observed light pain or a burning sensation following laser treatment. No side-effects were observed due to administration of antimicrobial agents | [178] |
Metronidazole: 500Â mg Amoxicillin: 375Â mg for 6Â months | Stage II periodontitis | Antibiotics reduced the count of sites containing PD as well as bleeding on probing. Antibiotics with SRP led to a decrease in the count of T. forsythia, F. nucleatum, and P. gingivalis | Majority of the side effects were related to gastrointestinal disturbances such as nausea, diarrhea, vomiting as well as stomach burning | ||
Metronidazole: 500Â mg Amoxicillin: 500Â mg for the time period of 6Â months | Stage III periodontitis | Treatment reduced the load of pathogens such as T. forsythia as well as T. denticola. It also decreased the number of PD sites | One patient reported mild intestinal disturbance and one experienced vertigo | [187] | |
Amoxicillin + Metronidazole + Doxycycline | Metronidazole: 250 mg Amoxicillin: 250 mg Doxycycline: 100 mg for 2 months | Stage III periodontitis | This drug treatment decreased the number of sites with PD | No side effects were reported related to the antibiotic administration | [188] |
Amoxicillin  + Clavulanic acid | 875 mg each 3 months | Stage I periodontitis | No difference was observed in PD between the control and test groups | / | [189] |
Doxycycline  + Clindamycin  + Metronidazole | Doxycycline: 200 mg Metronidazole: 500 mg Clindamycin: 150 mg for 2 years | Stage IV periodontitis | Treatment decreased PD, gained clinical attachment, and reduced the load of P. gingivalis and Actinobacillus Actinomycetemcomitans | / | [190] |
Azithromycin | 500Â mg for 6Â months | Stage II periodontitis | It helped to lessen PD and BANA scores | / | [191] |
500Â mg for 6Â months | Stage III periodontitis | No reduction in microbial load and PD was observed | Participants did not report any adverse effects from the use of antibiotic and placebo | [192] | |
500Â mg for the time period of 1Â year | Stage III periodontitis | Treatment regimen declined PD and periodontal pathogens significantly | Participants did not report any adverse effects from the use of antibiotic and placebo | [193] | |
500Â mg once a day for 5Â days | Stage III periodontitis | Administration of antibiotic failed to improve clinical parameters when compared to scaling and root planning (SRP) alone | One participant experienced nausea after taking antibiotic | ||
Metronidazole | 400Â mg thrice a day for 10Â days | Moderate to severe periodontitis (Stage III or IV) with Type 2 Diabetes Mellitus | SRP alone improved the periodontitis and glycemic control significantly | / | [196] |